Skip to main content
RVTY
NYSE Industrial Applications And Services

Revvity Sets Long-Range Targets at Investor Day: 6-8% Organic Growth, 75bps Annual Margin Expansion

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$157.03
Mkt Cap
$17.53B
52W Low
$81.22
52W High
$171.74
52W Position info
93% above low
Off High info
8.6% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

RVTY sits 93% above its 52-week low of $81.22.

Summary

At its 2026 Investor Day, Revvity laid out a long-range plan of 6-8% organic growth, 75bps annual margin expansion and double-digit adjusted EPS growth, with ~$5B of capital capacity through 2031. Formal 2027 guidance comes on the Q4 call.


Key Events · Earnings and Guidance · RVTY

  • Long-Range Plan Targets Disclosed

    Revvity set an LRP of 6-8% organic revenue growth (~200bps above market), 75bps annual adjusted operating margin expansion and double-digit adjusted EPS growth.

  • Segment Growth Targets

    Signals Software is targeted at 10-12% APV growth and Immunodiagnostics at 7-9%, versus 6-8% for Life Sciences Solutions and 3-5% for Reproductive Health; total Diagnostics 5-7% and total Life Sciences 7-9%.

  • 2027 Framework and Guidance Timing

    Management framed 2027 at ~6% organic growth, ~20bps incremental margin expansion, net interest of ~$85M, a ~19% tax rate and a flat share count; formal 2027 guidance will be given on the Q4 earnings call.

  • Capital Deployment Capacity

    Revvity cited ~$5B of capital capacity through 2031, directed at targeted M&A, consistent share repurchases and maintaining the existing dividend, with a commitment to an investment-grade credit rating.


Analysis · RVTY · Industrial Applications And Services

Revvity used its 2026 Investor Day to publish a formal long-range plan for the first time, and the numbers are the story: 6-8% organic revenue growth (roughly 200bps above its end markets), 75bps of annual adjusted operating margin expansion, and double-digit adjusted EPS growth. Segment targets put the fastest growth in Signals Software at 10-12% APV and Immunodiagnostics at 7-9%, while Reproductive Health lags at 3-5%. Management also framed 2027 at ~6% organic growth with a flat share count and ~$85M net interest, and pointed to ~$5B of capital capacity through 2031 for M&A, buybacks and the existing dividend. This is a multi-year commitment rather than a quarterly update, so it resets the bar investors will hold the company to; the formal 2027 guidance arrives on the Q4 earnings call.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, RVTY was trading at $157.03 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $17.5B. The 52-week trading range was $81.22 to $171.74. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

RVTY - Latest Insights

RVTY
Nov 03, 2026, 8:16 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $167.00
Real-time Price: $159.48 info
Change: -$7.52 (-5%) info
Market Cap: $17.53B info
RVTY
Nov 03, 2026, 6:00 AM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $157.77
Real-time Price: $159.48 info
Change: +$1.71 (+1%) info
Market Cap: $17.53B info
RVTY
Sep 09, 2026, 6:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $126.00
Real-time Price: $159.48 info
Change: +$33.48 (+27%) info
Market Cap: $17.53B info
RVTY
Aug 11, 2026, 4:06 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $115.73
Real-time Price: $159.48 info
Change: +$43.75 (+38%) info
Market Cap: $17.53B info
RVTY
Aug 04, 2026, 6:51 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $115.00
Real-time Price: $159.48 info
Change: +$44.48 (+39%) info
Market Cap: $17.53B info